Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,619.00    -20.00 (-0.76%)
Bid:
2,621.00
Ask:
2,625.00
Spread: 4.00 (0.153%)
Market Cap: £23.39b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Directorate Changes

19 Jan 2022 07:00

RNS Number : 8753Y
Experian plc
19 January 2022
 

Directorate Changes

 

19 January 2022  Experian, the global information services company, today announces that after 19 years at Experian, Kerry Williams has notified the Company of his intention to retire as Chief Operating Officer and as an Executive Director of the Company. To ensure a smooth succession process, Kerry will remain with Experian through to 31 March 2023.

 

Craig Boundy will succeed Kerry Williams. Craig has successfully led Experian's North America region for seven years, having joined Experian in November 2011 to lead the UK & Ireland region, and operated in a variety of leading management positions. Craig will assume the position of Chief Operating Officer on 1 April 2022 and will join the Board as an Executive Director of the Company from the conclusion of the Company's AGM in July 2022, when Kerry will step down from the Board.

 

Jennifer Schulz will assume the role of CEO, North America for Experian from 1 April 2022. Jennifer joined Experian in 2013 and is currently Group President of our North America Health and Automotive businesses and global Targeting and Data Quality (EDQ) businesses.

 

Mike Rogers, Experian's Chairman said "Experian has made tremendous progress over the past few years and we are immensely grateful to Kerry for his outstanding contribution to this success. Craig's commercial and operational expertise, as well as his commitment to fostering diversity, equity and inclusion within Experian, will bring equally deep knowledge and perspectives to the Experian plc Board."

 

Brian Cassin, Experian's Chief Executive Officer said "Kerry, Craig and Jennifer are extraordinary leaders and we are fortunate to have access to talent of this calibre so widely across Experian. Kerry has played a pivotal role in taking the business to the strong position it is in today. We thank him for this and wish him well for his retirement. Craig and Jennifer will build on these strong foundations as we progress our journey of innovation-led growth and I look forward to continuing to work closely with them in the years to come."

 

The Company confirms that there are no details to be disclosed under Listing Rule 9.6.13R, paragraphs (1) to (6) in respect of the appointment of Craig Boundy as an Executive Director of the Company from the conclusion of the Company's AGM in July 2022.

 

Contact:

Experian

Nadia Ridout-Jamieson Investor queries +44 (0)20 3042 4278

Gerry Tschopp Media queries

 

Tulchan

Graeme Wilson, Louise Male and Guy Bates +44 (0)20 7353 4200

 

About Experian

Experian is the world's leading global information services company. During life's big moments - from buying a home or a car, to sending a child to college, to growing a business by connecting with new customers - we empower consumers and our clients to manage their data with confidence. We help individuals to take financial control and access financial services, businesses to make smarter decisions and thrive, lenders to lend more responsibly, and organisations to prevent identity fraud and crime.

 

We have 20,000 people operating across 44 countries and every day we're investing in new technologies, talented people, and innovation to help all our clients maximise every opportunity. We are listed on the London Stock Exchange (EXPN) and are a constituent of the FTSE 100 Index.

 

Learn more at www.experianplc.com or visit our global content hub at our global news blog for the latest news and insights from the Group.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUWAWRUWUAAAR
Date   Source Headline
15th Jun 20225:36 pmRNSTransaction in Own Shares
15th Jun 202210:00 amRNSDirector/PDMR Shareholding
10th Jun 20223:39 pmRNSAnnual Financial Report
10th Jun 202210:00 amRNSElections for second interim dividend
9th Jun 20224:15 pmRNSDirector/PDMR Shareholding
31st May 202211:42 amRNSTotal Voting Rights
26th May 20225:08 pmRNSTransaction in Own Shares
25th May 20225:43 pmRNSTransaction in Own Shares
24th May 20225:22 pmRNSTransaction in Own Shares
23rd May 20225:41 pmRNSTransaction in Own Shares
20th May 20225:35 pmRNSTransaction in Own Shares
19th May 20225:38 pmRNSTransaction in Own Shares
18th May 20226:15 pmRNSTransaction in Own Shares
18th May 202211:30 amRNSShare repurchases
18th May 20227:00 amRNSFull-year financial report
16th May 20227:00 amRNSExperian agrees to acquire majority stake in MOVA
29th Apr 202212:01 pmRNSTotal Voting Rights
6th Apr 20229:35 amRNSAdditional Listing
31st Mar 20221:35 pmRNSTotal Voting Rights
30th Mar 20229:15 amRNSAdditional Listing
23rd Mar 20229:33 amRNSAdditional Listing
16th Mar 20229:30 amRNSBlock listing Interim Review
9th Mar 20224:41 pmRNSSecond Price Monitoring Extn
9th Mar 20224:37 pmRNSPrice Monitoring Extension
2nd Mar 20229:15 amRNSAdditional Listing
28th Feb 20222:07 pmRNSTotal Voting Rights
23rd Feb 20229:15 amRNSAdditional Listing
10th Feb 20224:45 pmRNSBond issue
10th Feb 20229:20 amRNSAdditional Listing
2nd Feb 20229:15 amRNSAdditional Listing
1st Feb 20225:56 pmRNSTransaction in Own Shares
31st Jan 202210:12 amRNSTotal Voting Rights
26th Jan 20222:04 pmRNSAdditional Listing
20th Jan 20225:45 pmRNSTransaction in Own Shares
19th Jan 202211:31 amRNSAdditional Listing
19th Jan 20227:00 amRNSDirectorate Changes
14th Jan 20225:53 pmRNSFirst interim dividend
14th Jan 20227:00 amRNSExperian Q3 FY22 trading update
11th Jan 20226:05 pmRNSTransaction in Own Shares
10th Jan 20225:54 pmRNSTransaction in Own Shares
7th Jan 20226:08 pmRNSTransaction in Own Shares
6th Jan 20226:17 pmRNSTransaction in Own Shares
31st Dec 202112:15 pmRNSTotal Voting Rights
31st Dec 20219:30 amRNSElections for first interim dividend
30th Dec 20213:26 pmRNSShare repurchases
15th Dec 20219:42 amRNSAdditional Listing
1st Dec 20219:15 amRNSAdditional Listing
30th Nov 20219:45 amRNSTotal Voting Rights
26th Nov 20213:27 pmRNSDirector/PDMR Shareholding
24th Nov 20219:15 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.